UV-stabilized protein-polymer compositions
View Patent ↗Protein-polymer compositions and processes for their production are provided where the compositions have improved resistance to ultraviolet light induced weathering and associated loss of enzyme activity. The incorporation of both a sterically hindered amine and an ultraviolet light absorber at a concentration of at least 5% by weight produces a curable or cured composition with UV stabilized enzyme activity that can be used as a bioactive coating with improved stain removal properties.
1. A curable protein-polymer composition comprising:
a polymer resin;
a cross-linker;
a bioactive enzyme; and
at least two ultraviolet light stabilizers whereby at least one light stabilizer is a sterically hindered amine, and at least one light stabilizer is a UV absorber, said UV absorber present at a concentration in excess of 5% by weight.
2. The composition of claim 1 , wherein the polymer resin is a hydroxyl-functionalized acrylate resin.
3. The composition of claim 1 wherein the crosslinker is a polyisocyanate.
4. The composition of claim 1 wherein said polymer resin and said cross-linker are covalently associated by a urethane bond.
5. A curable protein-polymer composition comprising:
a polymer resin;
a cross-linker;
a bioactive enzyme; and
at least two ultraviolet light stabilizers whereby at least one light stabilizer is a sterically hindered amine, and at least one light stabilizer is a UV absorber, said UV absorber present at a concentration in excess of 5% by weight, wherein said sterically hindered amine is 2,4-bis[N-Butyl-N-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)amino]-6-(2-hydroxyethylamine)-1,3,5-triazine.
6. The composition of claim 1 wherein said sterically hindered amine is present at 1% by weight.
7. The composition of claim 1 wherein said UV absorber has a 10% cut-off at a wavelength at or in excess of 380 nm.
8. The composition of claim 1 wherein said UV absorber has a band reject of 10% transmission or less in the wavelength range from 280 nanometers to 380 nanometers.
9. The composition of claim 1 wherein said UV absorber is present at a concentration of 8% by weight or greater.
10. The composition of claim 5 wherein said UV absorber is: C7-9 ester of [3-2h-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl)]-propionic acid; 2-(2H-benzotriazol-2-yl)-4,6-ditertpentylphenol; 2-(1-methyl-1-phenylethyl)-4-(1,1,3,3-tetramethylbutyl)-6-(benzotriazol-2-yl)phenol; methyl 3-[3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl]propanoate; or 2-(4-Benzoyl-3-hydroxyphenoxy)ethyl acrylate.
11. The composition of claim 10 wherein said polymer resin and said cross-linker are covalently associated by a urethane bond.
12. The composition of claim 10 wherein said UV absorber is present at a concentration of 8% by weight or greater.
13. A process for preparing a UV stabilized protein-polymer composite material, comprising:
providing an admixture of a polymer resin, a surfactant, a non-aqueous organic solvent, a sterically hindered amine, and a UV absorber, said UV absorber present at sufficient amounts to yield a final composition that is at least 5% by weight of said UV absorber;
mixing an aqueous solution containing isolated bioactive enzymes with the admixture, wherein said aqueous solution is substantially free of surfactant, to produce an emulsion;
and mixing the emulsion with a crosslinker to produce a curable UV stabilized protein-polymer composition.
14. The process of claim 13 further comprising curing the curable composition, thereby producing a cured UV stabilized protein-polymer composite material.
15. The process of claim 13 wherein said polymer resin is a hydroxyl-functionalized acrylate resin.
16. The process of claim 13 wherein said crosslinker is a polyisocyanate.
17. The process of claim 13 wherein said protein is an enzyme.
18. The process of claim 17 wherein said enzyme is α-amylase or an analogue thereof.
19. The process of claim 13 wherein said sterically hindered amine is 2,4-bis[N-Butyl-N-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)amino]-6-(2-hydroxyethylamine)-1,3,5-triazine present at 1% by weight.
20. The process of claim 13 wherein said UV absorber has a 10% cut-off at a wavelength in excess of 380 nm.
21. The process of claim 13 wherein said UV absorber is: C7-9 ester of [3-2h-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl)]-propionic acid; 2-(2H-benzotriazol-2-yl)-4,6-ditertpentylphenol; 2-(1-methyl-1-phenylethyl)-4-(1,1,3,3-tetramethylbutyl)-6-(benzotriazol-2-yl)phenol; methyl 3-[3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl]propanoate; or 2-(4-Benzoyl-3-hydroxyphenoxy)ethyl acrylate.
22. The process of claim 13 wherein said UV absorber is present at a final concentration of 8% by weight or greater.
23. A process of stabilizing enzyme activity in a protein-polymer curable composition against weathering from ultraviolet light comprising:
adding to a protein-polymer composition wherein said protein is an enzyme, at least two ultraviolet light stabilizers whereby at least one light stabilizer is a sterically hindered amine, and at least one light stabilizer is a UV absorber, said UV absorber present at a concentration in excess of 5% by weight.
24. A process of stabilizing enzyme activity in a protein-polymer curable composition against weathering from ultraviolet light comprising:
adding to a protein-polymer composition wherein said protein is an enzyme, at least two ultraviolet light stabilizers whereby at least one light stabilizer is a sterically hindered amine, and at least one light stabilizer is a UV absorber, said UV absorber present at a concentration in excess of 5% by weight, wherein said sterically hindered amine is 2,4-bis[N-Butyl-N-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)amino]-6-(2-hydroxyethylamine)-1,3,5-triazine.
25. The process of claim 23 wherein said sterically hindered amine is present at 1% by weight.
26. The process of claim 23 wherein said UV absorber has a 10% cut-off at a wavelength in excess of 380 nm.
27. The process of claim 23 wherein said UV absorber is added to produce a final concentration of 8% by weight or greater.